Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BioremFRA:R6D +1.65%67 EBIT per Share is €0.22 as of Mar. 2026. GuruFocus rates FRA:R6D with a GF Score™ of 67/100 and a GF Value™ of €1.67 (Modestly Overvalued). Among 2,499 Industrial Products companies, Biorem ranks better than 83.31% on this metric.
Biorem's EBIT per Share for the
three
months ended in Mar. 2026 was €0.01.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was €0.22.
During the past 12 months, the average EBIT per Share Growth Rate of Biorem was 71.40% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 33.00% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 43.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Biorem's EBIT per Share or its related term are showing as below:
FRA:R6D'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -54.5 Med: 15.7 Max: 55.9
Current: 33
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Biorem was 55.90% per year. The lowest was -54.50% per year. And the median was 15.70% per year.
FRA:R6D's 3-Year EBIT Growth Rate is ranked better than 83.31% of 2499
companies
in the Industrial Products industry
Industry Median: 4.8
vs FRA:R6D: 33.00
Biorem's EBIT for the
three
months ended in Mar. 2026 was €0.19 Mil.
Biorem (FRA:R6D) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Biorem EBIT per Share Related Terms
Biorem EBIT per Share Historical Data
* Premium members only.
The historical data trend for Biorem's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.22
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biorem (FRA:R6D) has a EBIT per Share of €0.22 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Biorem and its competitors. According to the industry distribution chart, Biorem ranks #417 out of 2499 companies in the Industrial Products industry, placing it in the top 16.7%.
Is Biorem's EBIT per Share too high?
Biorem's current EBIT per Share is €0.22. Based on the distribution chart, Biorem ranks #417 out of 2499 companies in the Industrial Products industry, which is in the top quartile — a strong position relative to peers. Overall, Biorem has a GF Score™ of 67/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Biorem's EBIT per Share compare to VLTO and ZWS?
According to the Industrial Products industry distribution chart, Biorem ranks #417 out of 2499 companies for EBIT per Share. This places Biorem in the top 17% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 4.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for an Industrial Products company?
The median EBIT per Share among Industrial Products companies is 4.80, based on 2,499 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Biorem and its competitors. For the Industrial Products industry, the median EBIT per Share is 4.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biorem's current EBIT per Share is €0.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biorem stock overvalued right now?
Based on GuruFocus' analysis, Biorem (FRA:R6D) is currently considered Modestly Overvalued. The stock's GF Value™ is €1.67, compared to a current price of €1.85 — trading 10.8% above its estimated fair value. The current EBIT per Share is €0.22. Biorem's overall GF Score™ is 67/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Biorem (FRA:R6D), the current EBIT per Share is €0.22 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Biorem (FRA:R6D) Overvalued in 2026?
Based on GuruFocus' analysis, Biorem stock appears to be overvalued.
The current stock price of €1.85 is trading 10.8% above its estimated GF Value™ of €1.67.
GuruFocus considers Biorem to be Modestly Overvalued.
Key valuation signals for FRA:R6D:
EBIT per Share: €0.22
GF Value™: €1.67 vs. price of €1.85 (10.8% above fair value)
No single metric tells the full story. See the FRA:R6D stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Biorem Inc is an environmental biotechnology company. It is involved in the manufacturing of a comprehensive line of high efficiency air pollution control systems that are used to eliminate odorous and harmful contaminants. The company's products include Biofilters, Biogas Solutions, Multi-Stage Systems, Biotrickling filters, and services such as Media Sampling and Analysis, Biological processes and testing, Media replacements and Spare parts, and other related services. The company derives revenues from the sale of standard products, construction projects for specialized products, and services for repairs and maintenance. The group has a business presence in Canada, the United States, China and others, of which key revenue is derived from the United States.
67GF Score
Get the complete analysis for FRA:R6D
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:R6D has been successfully added to your 
